{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:24:28Z","timestamp":1747207468853,"version":"3.40.5"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2021,5,20]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Human immunodeficiency virus (HIV) infection impairs renal function,\nthereby affecting renal phosphate metabolism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>We prospectively estimated the prevalence of phosphate abnormalities (mild, moderate\nto life-threatening hypophosphataemia, and hyperphosphataemia) before initiating antiretroviral\ntherapy (ART).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> A cross-sectional analysis was performed on 170 consecutive newly diagnosed ARTnaive,\nHIV-infected patients attending our HIV\/AIDS clinics over a period of one year. Fifty (50)\nscreened HIV-negative blood donors were used for comparison (controls). Blood and urine were\ncollected simultaneously for phosphate and creatinine assay to estimate fractional phosphate excretion\n(FEPi %) and glomerular filtration rate (eGFR).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>eGFR showed significant difference between patients\u2019 and controls\u2019 medians (47.89ml\/\nmin\/1.73m2 versus 60ml\/min\/1.73m2, p &lt;0.001); which denotes a moderate chronic kidney disease\nin the patients. Of the 170 patients, 78 (45.9%) had normal plasma phosphate (0.6-1.4\nmmol\/L); 85 (50%) had hyperphosphataemia. Grades 1, 2 and 3 hypophosphataemia was observed\nin 3 (1.8%), 3 (1.8%), and 1(0.5%) patient(s) respectively. None had grade 4 hypophosphataemia.\nOverall, the patients had significantly higher median of plasma phosphate than the controls, 1.4\nmmol\/L (IQR: 1.0 \u2013 2.2) versus 1.1 mmol\/L (IQR: 0.3 \u2013 1.6), p &lt;0.001, implying hyperphosphataemia\nin the patients; significantly lower median urine phosphate than the controls, 1.5 mmol\/L\n(IQR: 0.7 -2.1) versus 8.4 mmol\/L (IQR: 3.4 \u2013 16), p &lt;0.001), justifying the hyperphosphataemia\nis from phosphate retention; but a non-significantly lower median FEPi% than the controls, 0.96%\n(IQR: 0.3 -2.2) versus 1.4% (IQR: 1.2 -1.6), p &gt; 0.05. Predictors of FEPi% were age (Odds ratio,\nOR 0.9, p = 0.009); weight (OR 2.0, p &lt; 0.001); CD4+ cells count predicted urine phosphate\namong males (p = 0.029).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> HIV infection likely induces renal insufficiency with reduced renal phosphate clearance.\nThus, hyperphosphataemia is highly prevalent, and there is mild to moderate hypophosphataemia\nbut its life-threatening form (grade 4) is rare among ART-naive HIV patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526520666200707115259","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T16:40:41Z","timestamp":1594140041000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Phosphate Handling in Antiretroviral-naive HIV-Infected Patients"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-0852","authenticated-orcid":true,"given":"Tewogbade Adeoye","family":"Adedeji","sequence":"first","affiliation":[{"name":"Department of Chemical Pathology, Obafemi Awolowo University, Ile-Ife, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeon Adelani","family":"Adebisi","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Benue State University, Makurdi, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nife Olamide","family":"Adedeji","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusola Akanni","family":"Jeje","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotimi Samuel","family":"Owolabi","sequence":"additional","affiliation":[{"name":"Department of Medicine (HIV Unit), University of Abuja Teaching Hospital, Abuja, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1046\/j.1523-1755.1999.00748.x","volume":"56","author":"Klotman P.E.","year":"1999","unstructured":"Klotman P.E.; HIV-associated nephropathy. Kidney Int 1999,56(3),1161-1176","journal-title":"Kidney Int"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","volume":"11","author":"Bruggeman L.A.","year":"2000","unstructured":"Bruggeman L.A.; Ross M.D.; Tanji N.; Cara A.; Dikman S.; Gordon R.E.; Burns G.C.; D\u2019Agati V.D.; Winston J.A.; Klotman M.E.; Klotman P.E.; Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000,11(11),2079-2087","journal-title":"J Am Soc Nephrol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.ki.5000351","volume":"69","author":"Gerntholtz T.E.","year":"2006","unstructured":"Gerntholtz T.E.; Goetsch S.J.W.; Katz I.; HIV-related nephropathy: a South African perspective. Kidney Int 2006,69(10),1885-1891","journal-title":"Kidney Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/2325957415587570","volume":"14","author":"Adedeji T.A.","year":"2015","unstructured":"Adedeji T.A.; Adedeji N.O.; Adebisi S.A.; Idowu A.A.; Fawale M.B.; Jimoh K.A.; Prevalence and Pattern of Chronic Kidney Disease in Antiretroviral-Na\u00efve Patients with HIV\/AIDS. J Int Assoc Provid AIDS Care \n             xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/sagepub.com\/journalsPermissions.nav\">sagepub.com\/journalsPermissions.nav\n          2015,14(5),434-440","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/ijerph15071350","volume":"15","author":"Marotta C.","year":"2018","unstructured":"Marotta C.; Di Gennaro F.; Pizzol D.; Madeira G.; Monno L.; Saracino A.; Putoto G.; Casuccio A.; Mazzucco W.; The At Risk Child Clinic (ARCC): 3 Years of Health Activities in Support of the Most Vulnerable Children in Beira, Mozambique. Int J Environ Res Public Health 2018,15(7),1350","journal-title":"Int J Environ Res Public Health"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12889-018-5646-8","volume":"18","author":"Marotta C.","year":"2018","unstructured":"Marotta C.; Giaquinto C.; Di Gennaro F.; Chhaganlal K.D.; Saracino A.; Moiane J.; Maringhini G.; Pizzol D.; Putoto G.; Monno L.; Casuccio A.; Vitale F.; Mazzucco W.; Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting. BMC Public Health 2018,18(1),703","journal-title":"BMC Public Health"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1468-1293.2006.00407.x","volume":"7","author":"Buchacz K.","year":"2006","unstructured":"Buchacz K.; Brooks J.T.; Tong T.; Moorman A.C.; Baker R.K.; Holmberg S.D.; Greenberg A.; Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy. HIV Med HIV Outpatient Study (HOPS) Investigators2006,7(7),451-456","journal-title":"HIV Med"},{"year":"2011","key":"ref=8","unstructured":"Efavirenz\/Lamivudine\/Tenofovir disoproxil fumarate 600mg\/300mg\/300mg Tablets (Matrix Lab. Ltd) WHOPAR part 4August 2011  HA4662011"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","volume":"57","author":"Hall A.M.","year":"2011","unstructured":"Hall A.M.; Hendry B.M.; Nitsch D.; Connolly J.O.; Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 2011,57(5),773-780","journal-title":"Am J Kidney Dis"},{"key":"ref=10","first-page":"122","volume":"16","author":"Szczech L.A.","year":"2008","unstructured":"Szczech L.A.; Renal dysfunction and tenofovir toxicity in HIV-infected patients. Top HIV Med 2008,16(4),122-126","journal-title":"Top HIV Med"},{"key":"ref=11","first-page":"2241","author":"Bringhurst F.R.","year":"2004","unstructured":"Bringhurst F.R.; Demay M.B.; Krane S.M.; Kronenberg H.M.;  Harrison's Principles of Internal Medicine 2004,2241-2243","journal-title":"Harrison's Principles of Internal Medicine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jinf.2005.07.020","volume":"52","author":"Badiou S.","year":"2006","unstructured":"Badiou S.; De Boever C.M.; Terrier N.; Baillat V.; Cristol J.P.; Reynes J.; Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults? J Infect 2006,52(5),335-338","journal-title":"J Infect"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"Gallant J.E.","year":"2004","unstructured":"Gallant J.E.; Staszewski S.; Pozniak A.L.; DeJesus E.; Suleiman J.M.; Miller M.D.; Coakley D.F.; Lu B.; Toole J.J.; Cheng A.K.; Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 2004,292(2),191-201","journal-title":"JAMA"},{"key":"ref=14","first-page":"1905","author":"Endres D.B.","year":"1999","unstructured":"Endres D.B.; Rude R.K.;  Teitz textbook of clinical chemistry 1999,1905-1908","journal-title":"Teitz textbook of clinical chemistry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/ndt\/gfh658","volume":"20","author":"Izzedine H.","year":"2005","unstructured":"Izzedine H.; Hulot J.S.; Vittecoq D.; Gallant J.E.; Staszewski S.; Launay-Vacher V.; Cheng A.; Deray G.; Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. Nephrol Dial Transplant 2005,20(4),743-746","journal-title":"Nephrol Dial Transplant"},{"key":"ref=16","first-page":"19","author":"Norman J.","year":"1994","unstructured":"Norman J.;  How to write a paper 1994,19-32","journal-title":"How to write a paper"},{"journal-title":"Table for Grading the Severity of Adult and Pediatric Adverse Events","year":"2004","key":"ref=17","unstructured":"Table for Grading the Severity of Adult and Pediatric Adverse Events Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health2004"},{"key":"ref=18","first-page":"384","author":"Tietz N.","year":"1983","unstructured":"Tietz N.;  Clinical Guide to laboratory tests 1983,384","journal-title":"Clinical Guide to laboratory tests"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/clinchem\/28.7.1461","volume":"28","author":"Tanganelli E.","year":"1982","unstructured":"Tanganelli E.; Prencipe L.; Bassi D.; Cambiaghi S.; Murador E.; Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase. Clin Chem 1982,28(7),1461-1464","journal-title":"Clin Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.2215\/CJN.09191010","volume":"6","author":"Flandre P.","year":"2011","unstructured":"Flandre P.; Pugliese P.; Cuzin L.; Bagnis C.I.; Tack I.; Cabi\u00e9 A.; Poizot-Martin I.; Katlama C.; Brunet-Fran\u00e7ois C.; Yazdanpanah Y.; Dellamonica P.; Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol New AIDS Data group2011,6(7),1700-1707","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","volume":"93","author":"Swanepoel C.R.","year":"2018","unstructured":"Swanepoel C.R.; Atta M.G.; D\u2019Agati V.D.; Estrella M.M.; Fogo A.B.; Naicker S.; Post F.A.; Wearne N.; Winkler C.A.; Cheung M.; Wheeler D.C.; Winkelmayer W.C.; Wyatt C.M.; Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving\u00a0Global Outcomes (KDIGO) Controversies\u00a0Conference. Kidney Int 2018,93(3),545-559","journal-title":"Kidney Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e99469","DOI":"10.1371\/journal.pone.0099469","volume":"9","author":"Obirikorang C.","year":"2014","unstructured":"Obirikorang C.; Osakunor D.N.M.; Ntaadu B.; Adarkwa O.K.; Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control study. PLoS One 2014,9(6),e99469","journal-title":"PLoS One"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ndt\/gfx160.MP016","volume":"32","author":"Milburn J.","year":"2017","unstructured":"Milburn J.; Jones R.; Levy J.B.; Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant 2017,32(3),434-439","journal-title":"Nephrol Dial Transplant"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/jcm8081254","volume":"8","author":"Alfano G.","year":"2019","unstructured":"Alfano G.; Cappelli G.; Fontana F.; Di Lullo L.; Di Iorio B.; Bellasi A.; Guaraldi G.; Kidney Disease in HIV Infection. J Clin Med 2019,8(8),1254","journal-title":"J Clin Med"},{"key":"ref=25","first-page":"7","volume":"3","author":"Fabian J.","year":"2008","unstructured":"Fabian J.; Naicker S.; HIV and the Kidney. Tropical Journal of Nephrology 2008,3(1),7-22","journal-title":"Tropical Journal of Nephrology"},{"key":"ref=26","author":"Reynes J.","year":"2003","unstructured":"Reynes J.; Peyriere H.; Merle de Boever C.; Renal tubular injury and severe hypophosphataemia (Fanconi Syndrome) associated with tenofovir therapy. 10th Conference on Retroviruses and Opportunistic infection 2003","journal-title":"10th Conference on Retroviruses and Opportunistic infection"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","volume":"40","author":"Verhelst D.","year":"2002","unstructured":"Verhelst D.; Monge M.; Meynard J.L.; Fouqueray B.; Mougenot B.; Girard P.M.; Ronco P.; Rossert J.; Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002,40(6),1331-1333","journal-title":"Am J Kidney Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/00002030-200304110-00026","volume":"17","author":"Cr\u00e9put C.","year":"2003","unstructured":"Cr\u00e9put C.; Gonzalez-Canali G.; Hill G.; Piketty C.; Kazatchkine M.; Nochy D.; Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 2003,17(6),935-937","journal-title":"AIDS"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"Block G.A.","year":"1998","unstructured":"Block G.A.; Hulbert-Shearon T.E.; Levin N.W.; Port F.K.; Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998,31(4),607-617","journal-title":"Am J Kidney Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.2215\/CJN.06190611","volume":"6","author":"Sampaio M.S.","year":"2011","unstructured":"Sampaio M.S.; Molnar M.Z.; Kovesdy C.P.; Mehrotra R.; Mucsi I.; Sim J.J.; Krishnan M.; Nissenson A.R.; Kalantar-Zadeh K.; Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol 2011,6(11),2712-2721","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"Block G.A.","year":"2004","unstructured":"Block G.A.; Klassen P.S.; Lazarus J.M.; Ofsthun N.; Lowrie e.g.; Chertow G.M.; Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004,15(8),2208-2218","journal-title":"J Am Soc Nephrol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","year":"2007","unstructured":"Noordzij M.; Grootendorst D.C.; Beetz I.; Sijpkens Y.W.; van Manen J.G.; Boeschoten E.W.; Huisman R.M.; Krediet R.T.; Dekker F.W. Group tPs: High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007,22,2909-2916","journal-title":"Nephrol Dial Transplant"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/kisup.2013.88","volume":"3","author":"Kuro-O M.","year":"2013","unstructured":"Kuro-O M.; A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Suppl (2011) 2013,3(5),420-426","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ki.1993.189","volume":"43","author":"Kimmel P.L.","year":"1993","unstructured":"Kimmel P.L.; Ferreira-Centeno A.; Farkas-Szallasi T.; Abraham A.A.; Garrett C.T.; Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 1993,43(6),1347-1352","journal-title":"Kidney Int"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0272-6386(95)90648-7","volume":"26","author":"B\u00f3di I.","year":"1995","unstructured":"B\u00f3di I.; Abraham A.A.; Kimmel P.L.; Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 1995,26(2),286-291","journal-title":"Am J Kidney Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm0502-522","volume":"8","author":"Marras D.","year":"2002","unstructured":"Marras D.; Bruggeman L.A.; Gao F.; Tanji N.; Mansukhani M.M.; Cara A.; Ross M.D.; Gusella G.L.; Benson G.; D\u2019Agati V.D.; Hahn B.H.; Klotman M.E.; Klotman P.E.; Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002,8(5),522-526","journal-title":"Nat Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJM200106283442604","volume":"344","author":"Winston J.A.","year":"2001","unstructured":"Winston J.A.; Bruggeman L.A.; Ross M.D.; Jacobson J.; Ross L.; D\u2019Agati V.D.; Klotman P.E.; Klotman M.E.; Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001,344(26),1979-1984","journal-title":"N Engl J Med"},{"key":"ref=38","first-page":"1905","author":"Endres D.B.","year":"1999","unstructured":"Endres D.B.; Rude R.K.;  Teitz textbook of clinical chemistry 1999,1905-1908","journal-title":"Teitz textbook of clinical chemistry"},{"key":"ref=39","unstructured":"Background Package for NDA 21-356: VIREAD (tenofovir disoproxil fumarate. Gilead Sciences Inc"},{"key":"ref=40","first-page":"215","author":"Crook M.A.","year":"2006","unstructured":"Crook M.A.;  Clinical chemistry and metabolic medicine 2006,215","journal-title":"Clinical chemistry and metabolic medicine"},{"key":"ref=41","first-page":"153","author":"Walmsley R.N.","year":"1984","unstructured":"Walmsley R.N.; Guerin M.D.;  Disorders of fluid and electrolyte balance 1984,153-160","journal-title":"Disorders of fluid and electrolyte balance"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11255-008-9346-7","volume":"40","author":"Kovesdy C.P.","year":"2008","unstructured":"Kovesdy C.P.; Kalantar-Zadeh K.; Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 2008,40(2),427-440","journal-title":"Int Urol Nephrol"},{"key":"ref=43","first-page":"1078","volume":"20","author":"Taniguchi M.","year":"2010","unstructured":"Taniguchi M.; CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality. Clin Calcium 2010,20(7),1078-1087","journal-title":"Clin Calcium"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1053\/j.ajkd.2005.08.038","volume":"47","author":"Rosner M.H.","year":"2006","unstructured":"Rosner M.H.; Bolton W.K.; Core curriculum in nephrology. Am J Kidney Dis 2006,47(1),174-183","journal-title":"Am J Kidney Dis"},{"key":"ref=45","first-page":"825","volume":"73","author":"Keating F.R.","year":"1969","unstructured":"Keating F.R.; Jones J.D.; Elveback L.R.; Randall R.V.; The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. J Lab Clin Med 1969,73(5),825-834","journal-title":"J Lab Clin Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1056\/NEJMc0800696","volume":"359","author":"Cirillo M.","year":"2008","unstructured":"Cirillo M.; Ciacci C.; De Santo N.G.; Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 2008,359(8),864-866","journal-title":"N Engl J Med"},{"key":"ref=47","first-page":"301","volume":"38","author":"Day S.L.","year":"2005","unstructured":"Day S.L.; Leake Date H.A.; Bannister A.; Hankins M.; Fisher M.; Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice. J Acquir Immune Defic Syndr 2005,38(3),301-304","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1152\/physiol.00034.2008","volume":"24","author":"Berndt T.","year":"2009","unstructured":"Berndt T.; Kumar R.; Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 2009,24,17-25","journal-title":"Physiology (Bethesda)"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/ki.2011.27","volume":"121","author":"J\u00fcppner H.","year":"2011","unstructured":"J\u00fcppner H.; Phosphate and FGF-23. Kidney Int Suppl 2011,121(121),S24-S27","journal-title":"Kidney Int Suppl"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183521","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183521\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T14:27:29Z","timestamp":1634480849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183521\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526520666200707115259","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}